Atovaquone

In the US, Atovaquone (atovaquone systemic) is a member of the drug class miscellaneous antibiotics and is used to treat Babesiosis, Malaria, Pneumocystis Pneumonia, Pneumocystis Pneumonia Prophylaxis and Toxoplasmosis.

US matches:

UK matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

P01AX06

CAS registry number (Chemical Abstracts Service)

0095233-18-4

Chemical Formula

C22-H19-Cl-O3

Molecular Weight

366

Therapeutic Category

Antiprotozoal

Chemical Name

2-[trans-4-(p-chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthoquinone (WHO)

Foreign Names

  • Atovaquonum (Latin)
  • Atovaquon (German)
  • Atovaquone (French)
  • Atovacuona (Spanish)

Generic Names

  • Atovaquone (OS: USAN, BAN, DCF)
  • 566C (IS: Burroughs Wellcome)
  • 566C80 (IS: Burroughs Wellcome)
  • BW 566C-80 (IS)
  • Compound 566 (IS: Burroughs Wellcome)
  • DRG-0084 (IS)
  • UNII-Y883P1Z2LT (IS)
  • Atovaquone (PH: USP 34)

Brand Names

  • Atovaquone and Proguanil hydrochloride Glenmark (Atovaquone and Proguanil)
    Glenmark, United States
  • Malanil (Atovaquone and Proguanil)
    GlaxoSmithKline, South Africa
  • Malarone Bambini (Atovaquone and Proguanil (pediatric))
    GlaxoSmithKline, Italy
  • Malarone (Atovaquone and Proguanil)
    GlaxoSmithKline, Austria; GlaxoSmithKline, Australia; GlaxoSmithKline, Belgium; GlaxoSmithKline, Canada; GlaxoSmithKline, Switzerland; GlaxoSmithKline, Chile; GlaxoSmithKline, Czech Republic; GlaxoSmithKline, Germany; GlaxoSmithKline, Denmark; GlaxoSmithKline, Estonia; GlaxoSmithKline, Spain; GlaxoSmithKline, Finland; GlaxoSmithKline, France; GlaxoSmithKline, United Kingdom; GlaxoSmithKline, Greece; GlaxoSmithKline, Hong Kong; GlaxoSmithKline, Hungary; GlaxoSmithKline, Ireland; GlaxoSmithKline, Israel; GlaxoSmithKline, Iceland; GlaxoSmithKline, Italy; GlaxoSmithKline, Lithuania; GlaxoSmithKline, Luxembourg; GlaxoSmithKline, Latvia; GlaxoSmithKline, Malta; GlaxoSmithKline, Malaysia; GlaxoSmithKline, Netherlands; GlaxoSmithKline, Norway; GlaxoSmithKline, New Zealand; GlaxoSmithKline, Poland; GlaxoSmithKline, Portugal; GlaxoSmithKline, Sweden; GlaxoSmithKline, Singapore; GlaxoSmithKline, Slovenia; GlaxoSmithKline, United States
  • Malarone Junior (Atovaquone and Proguanil (pediatric))
    GlaxoSmithKline, Australia; GlaxoSmithKline, Belgium; GlaxoSmithKline, Switzerland; GlaxoSmithKline, Germany; GlaxoSmithKline, Netherlands; GlaxoSmithKline, Norway; GlaxoSmithKline, Sweden
  • Malarone Paediatric (Atovaquone and Proguanil (pediatric))
    GlaxoSmithKline, Estonia; GlaxoSmithKline, United Kingdom; GlaxoSmithKline, Greece; GlaxoSmithKline, Israel
  • Malarone Pediatric (Atovaquone and Proguanil (pediatric))
    GlaxoSmithKline, Canada
  • Mepron
    GlaxoSmithKline, Canada; GlaxoSmithKline, Poland; GlaxoSmithKline, United States
  • Wellvone
    GlaxoSmithKline, Australia; GlaxoSmithKline, Belgium; GlaxoSmithKline, Switzerland; GlaxoSmithKline, Germany; GlaxoSmithKline, Spain; GlaxoSmithKline, France; GlaxoSmithKline, United Kingdom; GlaxoSmithKline, Greece; GlaxoSmithKline, Italy; GlaxoSmithKline, Netherlands; GlaxoSmithKline, Sweden; GlaxoSmithKline, South Africa

International Drug Name Search

Glossary

TermDefinition
BANBritish Approved Name
DCFDénomination Commune Française
ISInofficial Synonym
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide
(web2)